Litigation Details for Bayer HealthCare LLC v. Nektar Therapeutics (N.D. Cal. 2017)
✉ Email this page to a colleague
Bayer HealthCare LLC v. Nektar Therapeutics (N.D. Cal. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-08-30 |
Court | District Court, N.D. California | Date Terminated | 2018-03-12 |
Cause | 28:2201 Declaratory Judgement | Assigned To | Lucy Haeran Koh |
Jury Demand | Plaintiff | Referred To | Howard R Lloyd |
Patents | 8,889,831 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Bayer HealthCare LLC v. Nektar Therapeutics
Details for Bayer HealthCare LLC v. Nektar Therapeutics (N.D. Cal. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-03-12 | 52 | 20 “’259 Patent”), and U.S. Patent No. 8,889,831 (the “’831 Patent”) (collectively, the “… 18 “’421 Patent”), U.S. Patent No. 8,143,378 (the “’378 Patent”), U.S. Patent No. 8,247,536 (the… 19 “’536 Patent”), U.S. Patent No. 8,519,102 (the “’102 Patent”), U.S. Patent No. 8,618,259 (the… eventually obtain U.S. Patent No. 7,199,223 (the “’223 Patent”), U.S. Patent No. 7,863,421 (the … Defendants’ U.S. Patent No. 7,858,749 (the “’749 Patent”). ECF No. 1. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |